CHRISTINE KRATCH: Open Payments
NPI 1891316030 · COLLEYVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,053 in 100 payments from 31 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,053
Food & beverage: $2,053
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $302 |
| Xeris Pharmaceuticals, Inc. | 13 | $238 |
| Amgen Inc. | 9 | $163 |
| Sequel Med Tech, LLC | 9 | $159 |
| Ascendis Pharma Endocrinology Inc | 4 | $105 |
| Madrigal Pharmaceuticals | 4 | $102 |
| Acella Pharmaceuticals, LLC | 4 | $90 |
| Dexcom, Inc. | 4 | $70 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $63 |
| BETA BIONICS, INC. | 4 | $58 |
Products named: RECORLEV, TWIIST, Wegovy, TEPEZZA, Ozempic, Yorvipath, REZDIFFRA, NP Thyroid 60.
Industry payments across TX — which companies pay providers there.
